MediciNova Announces Clinical Data from Subgroup Analyses of Completed Clinical Trial of MN-166 (ibudilast) in ALS Biotech Investing
Naturally Splendid Announces Prosnack Re-Branding and Purchase Order for National Convenience Store Chain Cannabis Investing News
NIH and Matinas BioPharma Announce Research Collaboration to Identify Novel HIV Therapy Utilizing LNC Platform Delivery Technology Biotech Investing
Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson’s Disease Dementia Biotech Investing
Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases Biotech Investing
Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months Pharmaceutical Investing
Exelixis Announces CELESTIAL Phase 3 Pivotal Trial Results Published in The New England Journal of Medicine Biotech Investing
